Filter Results
:
(438)
Show Results For
-
All HBS Web
(635)
- People (2)
- News (55)
- Research (438)
- Events (2)
- Multimedia (5)
- Faculty Publications (390)
Show Results For
-
All HBS Web
(635)
- People (2)
- News (55)
- Research (438)
- Events (2)
- Multimedia (5)
- Faculty Publications (390)
Sort by
- 02 Feb 2016
- First Look
February 2, 2016
agent-based simulation model of network emergence. Using data on technology partnerships from 1983 to 1999 among firms in the automotive, biotechnology and pharmaceuticals, chemicals, microelectronics, new materials, and...
View Details
Keywords:
Sean Silverthorne
- 29 Oct 2000
- Research & Ideas
The Entrepreneurial Venture: A Conversation
dormant at the time. But with the growth of the microprocessor and of biotechnology in the late 1970s, as well as the deregulation of the airline and financial services industries, new opportunities for eager entrepreneurs were created....
View Details
Keywords:
by Susan Young
- July 2013 (Revised November 2021)
- Module Note
Exploration vs. Exploitation
By: Willy Shih
This module note introduces James March's concept of exploration and exploitation, and the management challenge of balancing the allocation of resources to the two activities in the firm. The note also touches on the O'Reilly and Tushman paper on the ambidextrous...
View Details
Keywords:
Exploration And Exploitation;
Exploitation;
Research;
Scientific Research;
Product Commercialization;
Innovation and Invention;
Innovation and Management;
Innovation Leadership;
Innovation Strategy;
Technological Innovation;
Knowledge Acquisition;
Growth and Development Strategy;
Resource Allocation;
Strategic Planning;
Research and Development;
Science-Based Business;
Corporate Strategy;
Knowledge Sharing;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
United States
Shih, Willy. "Exploration vs. Exploitation." Harvard Business School Module Note 614-004, July 2013. (Revised November 2021.)
- Article
What to Know About Locating in a Cluster
By: Willy C. Shih and Sen Chai
As a study of two industry clusters in Denmark shows, factors that can make clusters attractive—easy people movement and knowledge spillovers—can also make it harder for individual companies to retain proprietary knowledge.
View Details
Keywords:
Clusters;
Clustering;
Competitiveness;
Life Sciences;
Telecommunications;
Science-based;
Research And Development;
Industry Clusters;
Research;
Innovation Strategy;
Innovation and Management;
Geographic Location;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Denmark
Shih, Willy C., and Sen Chai. "What to Know About Locating in a Cluster." Art. 57117. MIT Sloan Management Review 57, no. 1 (Fall 2015): 104–107.
- February 2014
- Case
BGI: Data-driven Research
By: Willy Shih and Sen Chai
BGI has the largest installed gene-sequencing capacity in the world, and to Zhang Gengyun, general manager of the Life Sciences Division, this represented an opportunity to apply his training as a plant breeder and his early career work as a biochemist to improving...
View Details
Keywords:
Genomics;
Gene Sequencing;
Life Sciences;
Plant Breeding;
Human Genome Program;
Beijing Genomics Institute;
BGI;
Rice Genome;
Technological Innovation;
Innovation Strategy;
Research;
Research and Development;
Science;
Genetics;
Science-Based Business;
Strategy;
Commercialization;
Corporate Strategy;
Information Technology;
Applications and Software;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
China;
United States
Shih, Willy, and Sen Chai. "BGI: Data-driven Research." Harvard Business School Case 614-056, February 2014.
- September 2009 (Revised December 2009)
- Supplement
Genzyme Center (C)
By: Michael W. Toffel and Aldo Sesia
Genzyme Corporation is in the midst of planning its new corporate headquarters, which incorporates many innovative green building features. After learning that the building as planned would likely earn a LEED Silver rating, an intermediate score in the LEED green...
View Details
Keywords:
Environmental Sustainability;
Corporate Social Responsibility and Impact;
Standards;
Cost vs Benefits;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
Toffel, Michael W., and Aldo Sesia. "Genzyme Center (C)." Harvard Business School Supplement 610-010, September 2009. (Revised December 2009.)
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
Pharmacyclics is a biotechnology company that had received FDA approval in late 2013 for its flagship asset Imbrivica (ibrutinib), a biologic treatment for chronic lymphocytic leukemia and two other even rarer blood malignancies. Entering...
View Details
Keywords:
Sean Silverthorne
- 03 May 2011
- First Look
First Look: May 3
had more than doubled its profits, deposits and advances; regained market share and won the Asian Banker Achievement award for the strongest bank in the Asia Pacific region. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/511114-PDF-ENG MorphoSys AG: The...
View Details
Keywords:
Sean Silverthorne
- February 2024 (Revised March 2024)
- Teaching Note
X: The Foghorn Decision
By: Kyle Myers and Walter Frick
Teaching Note for HBS Case No. 618-060.
View Details
Keywords:
Alternative Energy;
Energy Generation;
Energy Sources;
Climate Change;
Green Technology;
Selection and Staffing;
Knowledge;
Product Design;
Product Development;
Research and Development;
Risk and Uncertainty;
Science-Based Business;
Innovation and Invention;
Auto Industry;
Biotechnology Industry;
Chemical Industry;
Computer Industry;
Electronics Industry;
Green Technology Industry;
Technology Industry
- March 2017
- Case
Cantel Medical
By: John R. Wells and Gabriel Ellsworth
Cantel Medical Corporation provided infection prevention and control products and services for patients, caregivers, and other healthcare providers. In 2016, Cantel generated sales of $665 million and net profits of $60 million, double the levels of five years earlier....
View Details
Keywords:
Cantel;
Charles Diker;
Furniture Industry;
Matrix Organization;
Acquisition;
Mergers and Acquisitions;
Business Conglomerates;
Business Units;
Business Growth and Maturation;
Business Organization;
For-Profit Firms;
Chemicals;
Profit;
Revenue;
Geographic Scope;
Multinational Firms and Management;
Health;
Health Care and Treatment;
Business History;
Business or Company Management;
Goals and Objectives;
Growth and Development Strategy;
Organizational Structure;
Problems and Challenges;
Research and Development;
Opportunities;
Strategy;
Adaptation;
Business Strategy;
Competitive Strategy;
Corporate Strategy;
Diversification;
Expansion;
Information Technology;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
United States;
New Jersey
Wells, John R., and Gabriel Ellsworth. "Cantel Medical." Harvard Business School Case 717-482, March 2017.
- 01 Feb 2011
- First Look
First Look: Feb. 1
greenhouse gas emissions. The case describes challenges facing this small agricultural biotechnology company, notably uneven enforcement of intellectual property in emerging market countries and uncertainty regarding the provision and...
View Details
- 15 Oct 2008
- First Look
First Look: October 15, 2008
Science. Vol. 1, edited by Susan S. Silbey, 367-398. England: Ashgate Publishing, Limited, 2008 Abstract During the past 15 years, new biotechnology companies have promoted DNA typing as a sophisticated criminal and paternity...
View Details
Keywords:
Martha Lagace
- 19 May 2009
- First Look
First Look: May 19, 2009
the significance levels are lower. Cases & Course MaterialsAdnexus Therapeutics, Inc.: Considering the Exit Harvard Business School Case 609-015 Dr. John Mendlein, CEO of Adnexus Therapeutics Inc. (Adnexus), a private biotechnology...
View Details
Keywords:
Martha Lagace
- 12 May 2009
- First Look
First Look: May 12, 2009
Case 809-026 An executive from pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access...
View Details
Keywords:
Martha Lagace
- January 2016 (Revised February 2016)
- Course Overview Note
The Sustainable Core: Operations Management
By: Michael W. Toffel and L. Beril Toktay
This note is designed to help faculty embed environmental sustainability content into their core Operations Management course at the MBA or undergraduate level. It can also be used to identify cases with environmental content that can be used in operations electives...
View Details
Keywords:
Environmental Management;
Operations Management;
Sustainable Operations;
Environmental Regulation;
Operations;
Supply Chain;
Supply Chain Management;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
Toffel, Michael W., and L. Beril Toktay. "The Sustainable Core: Operations Management." Harvard Business School Course Overview Note 616-022, January 2016. (Revised February 2016.)
- 13 Jan 2009
- First Look
First Look: January 13, 2009
biotechnology leaders need to understand clinical trial management. Likewise, with a growing variety of new product introductions requiring pre-market testing, managers and analysts in many business sectors will benefit from understanding...
View Details
Keywords:
Martha Lagace
- October 2020 (Revised April 2022)
- Case
When Institutions Fail: HIV/AIDS in the 1980s
By: Tom Nicholas and Christian Godwin
During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting...
View Details
Keywords:
Ethics;
Policy;
Government and Politics;
Health Pandemics;
History;
Rights;
Media;
Organizations;
Business and Community Relations;
Religion;
Social Psychology;
Identity;
Prejudice and Bias;
Social Issues;
Public Opinion;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
United States
Nicholas, Tom, and Christian Godwin. "When Institutions Fail: HIV/AIDS in the 1980s." Harvard Business School Case 821-002, October 2020. (Revised April 2022.)
- 18 Dec 2012
- First Look
First Look: December 18
pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access to its potentially...
View Details
Keywords:
Carmen Nobel
- May 20, 2016
- Comment
World Health Organization Lacks Leadership to Combat Pandemics
By: John A. Quelch
When it comes to emergency preparedness for pandemics, the World Health Organization is falling short. It has not provided prompt and clear leadership to the world in combating either the Ebola or Zika viruses. Its leadership has been low energy, its representatives...
View Details
Keywords:
Global Health;
World Health Organization;
World Bank;
Pandemics;
Emergency Preparedness;
Experience and Expertise;
Decisions;
Forecasting and Prediction;
Communication Strategy;
Nonverbal Communication;
Framework;
Governance;
Government and Politics;
Health;
Management;
Practice;
Problems and Challenges;
Projects;
Risk and Uncertainty;
Human Needs;
Civil Society or Community;
Social Issues;
Welfare or Wellbeing;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Africa;
Asia;
Europe;
Latin America;
North and Central America;
South America;
West Indies
Quelch, John A. "World Health Organization Lacks Leadership to Combat Pandemics." Harvard Business School Working Knowledge (May 20, 2016).
- 06 Mar 2012
- First Look
First Look: March 6
healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a distributor (medical), a DME licensee and seller, a...
View Details
Keywords:
Sean Silverthorne